JP2022028645A5 - - Google Patents

Download PDF

Info

Publication number
JP2022028645A5
JP2022028645A5 JP2021153771A JP2021153771A JP2022028645A5 JP 2022028645 A5 JP2022028645 A5 JP 2022028645A5 JP 2021153771 A JP2021153771 A JP 2021153771A JP 2021153771 A JP2021153771 A JP 2021153771A JP 2022028645 A5 JP2022028645 A5 JP 2022028645A5
Authority
JP
Japan
Prior art keywords
domain
antibody
binding domain
antigen binding
subunit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021153771A
Other languages
English (en)
Japanese (ja)
Other versions
JP7653881B2 (ja
JP2022028645A (ja
Filing date
Publication date
Priority claimed from PCT/EP2019/086144 external-priority patent/WO2020127619A1/en
Application filed filed Critical
Publication of JP2022028645A publication Critical patent/JP2022028645A/ja
Publication of JP2022028645A5 publication Critical patent/JP2022028645A5/ja
Application granted granted Critical
Publication of JP7653881B2 publication Critical patent/JP7653881B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021153771A 2018-12-21 2021-09-22 Ｃｄ３に結合する抗体 Active JP7653881B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18214994.8 2018-12-21
EP18214994 2018-12-21
PCT/EP2019/086144 WO2020127619A1 (en) 2018-12-21 2019-12-19 Antibodies binding to cd3
JP2021534306A JP7061733B2 (ja) 2018-12-21 2019-12-19 Ｃｄ３に結合する抗体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021534306A Division JP7061733B2 (ja) 2018-12-21 2019-12-19 Ｃｄ３に結合する抗体

Publications (3)

Publication Number Publication Date
JP2022028645A JP2022028645A (ja) 2022-02-16
JP2022028645A5 true JP2022028645A5 (cg-RX-API-DMAC10.html) 2022-12-27
JP7653881B2 JP7653881B2 (ja) 2025-03-31

Family

ID=78819196

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021126403A Active JP7090780B2 (ja) 2018-12-21 2021-08-02 Ｃｄ３に結合する抗体
JP2021153771A Active JP7653881B2 (ja) 2018-12-21 2021-09-22 Ｃｄ３に結合する抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021126403A Active JP7090780B2 (ja) 2018-12-21 2021-08-02 Ｃｄ３に結合する抗体

Country Status (1)

Country Link
JP (2) JP7090780B2 (cg-RX-API-DMAC10.html)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2753158A1 (en) * 2009-02-23 2010-08-26 Glenmark Pharmaceuticals S.A. Humanized antibodies that bind to cd19 and their uses
WO2014028748A1 (en) * 2012-08-15 2014-02-20 Irm Llc Interleukin 2 antibodies and antibody complexes
CN110437337B (zh) * 2013-02-26 2024-07-30 罗切格利卡特公司 双特异性t细胞活化性抗原结合分子
PL3177643T3 (pl) 2014-08-04 2019-09-30 F.Hoffmann-La Roche Ag Dwuswoiste cząsteczki wiążące antygen aktywujące komórki T
RS61010B1 (sr) * 2014-11-20 2020-11-30 Hoffmann La Roche Bispecifični antigen vezujući molekuli koji aktiviraju t ćelije protiv folr1 i cd3
TWI744242B (zh) 2015-07-31 2021-11-01 德商安美基研究（慕尼黑）公司 Egfrviii及cd3抗體構築體
WO2017055388A2 (en) 2015-10-02 2017-04-06 F. Hoffmann-La Roche Ag Bispecific t cell activating antigen binding molecules
CN109843926B (zh) 2016-09-30 2023-01-20 豪夫迈·罗氏有限公司 针对cd3的双特异性抗体

Similar Documents

Publication Publication Date Title
JP2019533441A5 (cg-RX-API-DMAC10.html)
JP2021507698A5 (cg-RX-API-DMAC10.html)
IL269395B2 (en) Immunoconjugation of anti-PD-1 antibody with IL-2 or IL-15 mutation
JP2024534545A5 (cg-RX-API-DMAC10.html)
FI3802598T3 (fi) Dll3/cd3:a sitovia proteiineja syövän hoitamiseksi
FI3177643T5 (fi) T-soluja aktivoivia bispesifisiä antigeeniä sitovia molekyylejä
JP2019502712A5 (cg-RX-API-DMAC10.html)
JP2022551969A5 (cg-RX-API-DMAC10.html)
HRP20200306T1 (hr) Bispecifične molekule vezane na antigene koji aktiviraju t stanice specifične za cd3 i cea
JP2023511376A5 (cg-RX-API-DMAC10.html)
JP2021533779A5 (cg-RX-API-DMAC10.html)
CN106164095A (zh) 多特异性抗体
JP2022551081A5 (cg-RX-API-DMAC10.html)
JP2023554500A5 (cg-RX-API-DMAC10.html)
JP2020515277A5 (cg-RX-API-DMAC10.html)
JP2017537896A5 (cg-RX-API-DMAC10.html)
RU2019134462A (ru) Антитела, связывающиеся с steap-1
JP2023516195A5 (cg-RX-API-DMAC10.html)
JP2023139025A (ja) 二重特異性抗原結合コンストラクト
JP2025504909A5 (cg-RX-API-DMAC10.html)
CN120603850A (zh) 抗cmet抗体及使用方法
JP2024542235A5 (cg-RX-API-DMAC10.html)
RU2023135060A (ru) Антитела, связывающиеся с cd3
RU2019122411A (ru) Анти сd3 антитело и молекула, содержащая это антитело
RU2026104696A (ru) Антитела, связывающиеся с cd3